Mycobacterium tuberculosis (Mtb) has co-evolved with humans for millennia and developed multiple mechanisms to evade host immunity. Restoring host immunity in order to shorten existing therapy and improve outcomes will require identifying the full complement by which host immunity is inhibited. Perturbing host DNA methylation is a mechanism induced by chronic infections such as HIV, HPV, LCMV and schistosomiasis to evade host immunity.
Introduction:
Tuberculosis (TB) continues to be a global problem with 10 million cases and over a million deaths each year 1 . Anti-TB therapy requires six months, despite the majority of individuals becoming culture negative within the first two months of therapy. It is unique to mycobacterial disease for therapy to be required for so many months after culture conversion.
While multiple mechanisms of TB-induced immunosuppression have been identified, it is unknown why anti-TB therapy must be continued for months after an individual becomes culture negative. Further, after successful TB therapy, patients have a 13-fold increased risk of disease recurrence compared to the general population 2 . Recurrent disease could be related to strain virulence, environmental risk factors or persistent perturbations of host immunity. It is therefore critical to identify mechanisms of host immunosuppression that persist despite successful TB therapy. TB has been recognized as an archetypical chronic infection since at least 1882. Since 1984, the Clone 13 strain of murine LCMV has emerged as the prototypical animal model of chronic infection 3 . Chronic infection with clone 13 LCMV induces immune exhaustion, which is defined by decreased antigen induced immune cell proliferation, decreased immune effector function and increased expression of immune checkpoint inhibitors [4] [5] [6] . Immune exhaustion is mediated by epigenetic alterations, conformational changes in immune cell DNA methylation and chromatin architecture that inhibits robust cell-mediated immunity 7 . These epigenetic changes are driven by DNA methyltransferase (DNMT) and the Enhancer of Zeste 2 Polycomb Repressive complex (EZH2) that imbues a repressive chromatin state, resulting in an immune non-responsive state [8] [9] [10] [11] . DNA methylation is a common and stable epigenetic alteration that blocks transcription factor binding and inhibits gene expression and mediates immune exhaustion. Once exhausted, the epigenetic perturbations persist and the immune phenotype remains subdued even if cells are rested for three weeks, or if they are transferred into healthy, non-infected mice 10, 12 . Similarly, humans chronically infected with HIV or schistosomiasis have DNA methylation perturbations of immunity that persist for months to years after successful therapy 8, 13, 14 .
Given that chronic antigen stimulation from HIV, schistosomiasis, or LCMV induces long-lasting epigenetic-mediated immune exhaustion, we were concerned that TB disease may also result in persistent detrimental epigenetic changes 8, 10, [13] [14] [15] . We hypothesized that TB patients would have a DNA methylation landscape similar to chronic LCMV. Mouse models of chronic LCMV have demonstrated persistent epigenetic perturbations, with hypomethylating agents capable of restoring host immunity 9, 10, 12 . We thought it pertinent to investigate the longitudinal DNA methylation of host immune cells before and after successful anti-TB therapy.
In a cohort of microbiologically-confirmed adults with pulmonary TB from Eswatini, TB patients exhibit a hypo-responsive immune phenotype with decreased immune proliferation and decreased mycobacterial and mitogen induced cytokine production in association with DNA hyper-methylation of multiple critical immune genes and pathways. These DNA methylation perturbations persisted 6 months after successful anti-TB therapy and identifies a plausible mechanisms of suppressed host immunity.
Results:
We previously described a cohort of asymptomatic, TB-exposed children from Eswatini (formerly known as Swaziland), with schistosomiasis induced DNA hyper-methylation and associated inhibition of BCG and Mycobacterium tuberculosis (Mtb) immunity 14 . Here, to evaluate if TB induces similar DNA methylation perturbations that correspond with immune exhaustion, we assessed adults with TB symptoms and microbiologically-confirmed (by culture and/ or Gene Xpert) pulmonary TB. We compared their immune phenotype and DNA methylation status to their asymptomatic, healthy household contacts who remained asymptomatic for 12 months after initial exposure ( Fig.1 ). All study participants were BCG vaccinated, as determined either via vaccine records and/ or BCG scar. HIV screen was performed at time of study initiation and then annually. TB treatment outcomes were defined by both WHO criteria and a simplified clinically relevant definition 16 . Fig. 1c ). A recent report demonstrated that TB-exposed individuals who did not progress to active disease had increased abundance of cytotoxic NK cells 20 . Only household contacts that remained asymptomatic and did not progress to active TB disease for 12 months were included in this analysis and similar to the recent report, household contacts in this cohort that did not progress had increased IFN-γ, T-bet and perforin production from NK cells compared to individuals with TB ( Fig 1b; Supplemental Fig. 1 ). In contrast, TB patients had CTLs and helper T cells with increased perforin production (Supplemental Fig. 1 ).
The TB DNA methylome resembles the immune exhaustion epigenetic landscape:
Epigenetic mechanisms mediate immune exhaustion and therefore we evaluated the global DNA methylation status of TB participants using the EPIC array. From bulk PBMCs, cellspecific DNA methylation was determined using epigenetic deconvolution (EDEC) 21 . EDEC identified global differential methylation changes in Helper T cells, CTLs, NK cells and monocytes both at baseline and 6 months after completion of successful ATT, 12 months after study enrollment (Fig. 2d ). The IL-2-STAT5 pathway, a critical component of cell proliferation, was differentially methylated at baseline and 6 months after successful therapy in all lymphocyte subsets. The PI3K-AKT pathway, which modulates the intracellular signaling of the immuno-metabolic pathway in both adaptive and innate cells, was differentially methylated in all cell types except CD4 + T cells. Similarly, the TNF-NFϰB signaling pathway was differentially methylated in all evaluated cell types except Helper T cells. IFN-γ signaling, critical to antimycobacterial immunity, was differentially methylated in all cell types at baseline and 6 months after the completion of ATT (Fig 2b) . Specifically, the lymphocyte subsets (CD4 + Helper T cells, CD3 + CD8 + CTLs and CD3 -CD56 + NK cells) demonstrated DNA hyper-methylation the IFN-γ signaling pathway, while this pathway was hypo-methylated in monocytes ( Fig 3) .
To validate the deconvolution results, CD4 + T cells were isolated and DNA methylation Specifically, IL12B demonstrated 6.1-fold increased methylation (p = 0.007); IL12RB2 was hyper-methylated 35.2-fold ( p < 0.03); TYK2 demonstrated 17.7-fold increased methylation (p = 0.008); IFNGR1 was hyper-methylated 24.0-fold (p = 0.007); JAK1 and JAK2 demonstrated 33.3 and 11.7-fold increased DNA methylation (p = 0.004 and 0.03), respectively ( Fig. 4 ).
STAT1 and IRF1 were not statistically hyper-methylated (p = 0.21 and 0.15, respectively; Fig.   4b ). Regulation of immunity is epigenetically controlled at specific pathways, but also by a network of transcription factors 24 . By MSRE-qPCR, the CD4 + T cells from TB patients demonstrated DNA hyper-methylation of the transcription factors NFATC1, BATF3, ID2, PPARG, RUNX2, IRF5 and IKZF1 (p< 0.001; Fig. 4c ).
TB patients have decreased mitogen responsiveness: TB patients demonstrated DNA
hyper-methylation of IL-2, IL-6, TNF and IFN-γ signaling pathways (Fig 2-4 ). Each of these pathways result in activation of mitogen activated protein kinase (MAPK) and each cytokine is also downstream of mitogen activation. We therefore hypothesized that TB patients would have decreased mitogen responsiveness. Freshly collected whole blood was stimulated overnight with mitogen and multiplexed ELISA was performed on the supernatant. The TNF-NFϰB signaling pathway and the gene TNF were hyper-methylated in CD14, CD8 and CD56 cells of TB patients ( Fig. 3 ). While the baseline production of TNF was similar (3.7 vs 1.4 pg/mL; p = 0.2), after mitogen stimulation, TB patients exhibited 72% decreased up regulation of TNF by ELISA (80.5 vs 293 pg/ mL; p = 0.01; Fig. 5 decrease in IL-12-induced IFN-γ up-regulation (p = 0.03; Fig.7 ).
Discussion
Despite becoming culture-negative after two months of anti-tuberculosis therapy, patients with TB require six grueling months of antibiotics 30 . However, even after these six months of antibiotics, patients with successful anti-TB therapy have a 13-fold increased risk of recurrent TB compared to the general population 2 . Epigenetic-mediated immune exhaustion has been demonstrated to impede immunotherapy in murine LCMV experimental models 9 , but it has not previously been evaluated as a potential etiology of TB induced immune exhaustion.
Here we demonstrate that TB patients have DNA hyper-methylation in critical immune pathways including the IL-12-IFN-γ pathway and this is associated with decreased mitogen, mycobacterial, IL-12 and IFN-γ immune responsiveness.
Anergy in TB patients has been described since at least the 1940s. Depending on the definition employed for anergy, approximately 5 -25% of TB patients fail to mount a positive skin reaction to tuberculin, or failure to release IFN-γ after exposure to mycobacterial antigens [31] [32] [33] [34] [35] [36] [37] . TB patients failing to produce Mtb-specific IFN-γ have increased mortality 38 , potentially suggesting more advanced disease. The TB-induced anergy is not specific to mycobacterial antigens, with TB patients also exhibiting decreased responsiveness to Candida and histoplasmin antigens 39 . HIV increases the likelihood of anergy 34 , but in some cohorts up to 46% of HIV-negative TB cases are anergic 40 . Modern immune analysis has characterized TB-induced immune exhaustion demonstrating that TB patients have decreased IFN-γ, IL-2 and proliferative capacity with an increase in immune checkpoint inhibitors, such as PD-1, TIM3 and CTLA-4 18, 19, 41, 42 . In addition to limiting critical cytokines, such as IFN-γ, previous studies have demonstrated that immune cells from TB patients to have downstream defects in cell signaling including decreased IFN-γ-inducible gene expression 43, 44 . DNA hypermethylation has been demonstrated to inhibit robust immunity in LCMV models, and here we identify that the DNA hyper-methylation is associated with suppressed immunity during TB.
Immune exhaustion after chronic antigen stimulation is not limited to TB and has been observed in many instances of persistent inflammation due to chronic infection, sepsis or cancer 6, [45] [46] [47] . Continuously expressed tumor antigens induce immune exhaustion via upregulation of DNA methyltransferases and the transcriptionally repressive EZH2 complex, both known moderators of epigenetic-mediated immune exhaustion 12, 48 . Epigenetic-mediated immune exhaustion persists even if cells are rested for three weeks, or if they are transferred into healthy, non-infected mice 10, 12 . In clinical cohorts, even two years after successful aviremia, patients infected with HIV retain detrimental epigenetic marks 8, 13 . Similarly, 6 months after successful deworming, children previously schistosomiasis infected retain detrimental DNA methylation marks 14 . In this report, six-months after completing successful anti-TB therapy, the immune system demonstrates persistent DNA hyper-methylation perturbations.
Patients in this cohort were only followed six months after completion of ATT, and longitudinal studies will need to assess if persistent detrimental DNA methylation marks are correlative with recurrent TB disease.
Chronic LCMV models have demonstrated that immune exhaustion is moderated by broad remodeling of the epigenetic landscape and that these epigenetic perturbations Fig. 6) , reduced mitogen-induced cytokine production ( Fig. 5 ) and
reduced IL-12-inducible IFN-γ production ( Fig. 7) .
Host-directed immunotherapy has been identified as a priority research area to improve TB treatment outcomes among the 10 million people afflicted each year. TB is an archetypical chronic infection known to inhibit host immunity and herein, we demonstrate that decreased immune responsiveness to IL-12, IFN-γ, mitogen, and mycobacterial antigens is associated with DNA hyper-methylation of critical immune transcription factors and the canonical and noncanonical IL-12-IFN-γ signaling pathway. The persistent DNA methylation perturbations that we have demonstrated are a plausible explanation for why successful TB therapy must be continued for months after Mtb culture conversion. These data suggest it is critical to now evaluate whether modulating DNA methylation can effectively augment host antimycobacterial immunity.
Methods: Ethics, cohort enrollment and study samples
The study protocol was reviewed by the Baylor College of Medicine Children's Foundation-Swaziland, Baylor College of Medicine and Eswatini National Health Research and Review Board. All participation was voluntary and implemented in accord with the institutional and international guidelines for the Protection of Human Subjects in concordance with the Declaration of Helsinki. In this analysis, immune cells of TB participants were analyzed if they had pulmonary disease as defined by symptoms of TB (cough, fevers, weight loss, etc) and microbiologically confirmed disease by sputum Gene Xpert and/ or culture. All participants were screened for HIV. Individuals with helminth co-infection (by urine or stool microscopy, and urine and stool qPCR) were excluded from this analysis. Healthy controls were household contacts of TB patients with a TB contact score 54 of five or greater and excluded if they progressed to active TB and did not remain asymptomatic for 12-months. All individuals were BCG vaccinated as confirmed by BCG scar and/ or vaccine card.
Multi-Dimensional Immune Profiling
Peripheral blood mononuclear cells were isolated using Ficoll-separation and cryopreserved in liquid nitrogen. Upon thawing, >70% viability was determined by trypan and by lymphocyte amine reactive dye by flow cytometry. PBMCs were stimulated under the following conditions: a) DMSO vehicular control, b) 2.5 μg each of ESAT-6 and CFP-10 overlapping peptide pools, c) 5 μg of BCG sonicate and d) 0.2 μL of staphylococcal enterotoxin B. Stimulations took place in the presence of co-stimulation (CD28/CD49) for 18 hours with monensin and brefeldin A for the last 12 hours. Cells were stained with an amine reactive dye (Ghost Dye), surface antibodies (CD4, CD8, CD56 and PD-1) and intracellular antibodies (CD3, Ki-67, IFN-γ, TNF, IL-4, IL-10, IL-13, perforin, T-bet and GATA-3) and acquired on an LSR II Fortessa.
DNA methylation
Genomic DNA was isolated using the DNeasy kit from 1x10 6 PBMC or magnetic-bead isolated CD4 + T cells with a minimum of 80% viability. Nucleic acid quantity and quality was examined using a Qubit 3.0 fluorometer and Agilent 4200 Tape Station System and 500ng of gDNA was bisulfite treated prior to running the Illumina Infinium MethylEPIC array. Methylation IDAT files were preprocessed and normalized using the R statistical system Bioconductor ) minfi package with probes with greater than 2, or less than 0.5-fold differential methylation with p-values < 0.05 being considered significant. Gene ontology (GO) and Gene Set Enrichment Analysis was implemented using the Molecular Signature Database (MSigDB) using hyper-geometric distribution that accounts for multiple comparisons. 55 Epigenetic deconvolution was implemented as previously described 56 . The Epitect II DNA Methylation Enzyme kit was used to validate methylome results as previously described. In brief, gDNA underwent methylation specific enzymatic digestion with the percentage of methylated and unmethylated DNA determined relative to mock and double digest determined by quantitative PCR 14, 57 .
Gene expression
PBMCs were stimulated overnight with IFN-γ (50 ng/mL) or media control (PBS) for 16 hours followed by RNA isolation and gene expression evaluated using the Nanostring nCounter Human Immunology 2 probe set. Data was normalized using eight negative controls and ten housekeeping genes.
Statistical analysis
Flow cytometry data was processed using FlowJo (TreeStar, Ashland, OR) and GraphPad 6.0 (graphPad Software). CITRUS was implemented using CytoBank (http://www.cytobank.org) using nearest shrunken centroid (PAMR) with a minimum cluster size of 10%, cross validation fold of 10 and an FDR of 1%. DNA methylEPIC probes were considered significant if they demonstrated greater than 2 or less than 0.5-fold differences from controls with a p-value < 0.05. Gene expression, flow cytometry and targeted MSRE DNA methylation was evaluated using nonparametric Mann-Whitney U test. Figure 1 : TB patients exhibit an exhausted immune phenotype. PBMCs from individuals with Tuberculosis (TB; n = 29) and their asymptomatic household contacts (HC; n = 49) underwent antigenic stimulation with BCG sonicate followed by flow-cytometry based multi-dimensional immune profiling. CITRUS (cluster identification, characterization, and regression) identified CD4, CD8, CD3 and CD56 subsets. We further defined NK cells as CD3 -CD56 + cells. Fresh whole blood (0.8 -1.2 mL) from TB patients (n = 40) and asymptomatic healthy household contacts (n = 39) was stimulated overnight with and without mitogen and the resultant plasma was evaluated for cytokine and chemokine upregulation using a bead-based multiplex ELISA. Mann-Whitney p-values < 0.05, < 0.01 and < 0.001 depicted by *, **, and *** respectively.
Figures:
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Nil Slope Mitogen Nil Slope Mitogen PBMCs from TB patients (n = 15) and asymptomatic healthy household contacts (n = 10) were stimulated overnight without stimulation (PBS media control), with BCG sonicate (5μg) or with IL-12 (20ng/mL) and BCG (minimum of 0.5 x10 6 PBMCs per condition) and evaluated by multi-dimensional flow cytometry the following morning.
(A) Representative dot plots of NK (CD3 -CD56 + ) production of IFN-γ and TNFα after no stimulation ("Nil stim"), BCG, or IL-12 and BCG stimulation. (B) tSNE (t-Distributed Stochastic Neighbor Embedding dimension reduction) clustering demonstrating the cellspecific (CD3, CD4, CD8 and CD56) contribution of IFN-γ production after IL-12 and BCG stimulation with blue indicating no protein expression, and green, yellow and red indicating increased protein expression.
(C-D) Bar graphs demonstrating the percent of CTL (CD3 + CD8 + and NK cell (CD3 -CD56 + ) producing IFN-γ after IL-12 and BCG stimulation. Mann-Whitney p = 0.3 and 0.008 for CTLs and NK cells, respectively.
Supplemental Figure 1: TB patients exhibit an exhausted immune phenotype. PBMCs from individuals with
Tuberculosis (TB; n = 29) and their asymptomatic household contacts (HC; n = 49) had their PBMCs divided into PBS vehicle non-stimulated control ("Nil stim"), BCG stimulated, ESAT-6 and CFP-10 stimulated and Staphylococcal-enterotoxin B (SEB) stimulated cells (0.5 -1 x 10 6 cells per condition). Cells were stimulated overnight with monensin and BFA for the final 12 hours. The BCG immune response is presented in Figure 1 . Citrus (cluster identification, characterization, and regression) identified CD4, CD8, CD3 and CD56 subsets. (S1A) Mtb-specific immune response: CITRUS clustering identifies CD4, CD8 and NK populations with CD3 signal depicted by color gradient. After stimulation with ESAT-6 and CFP-10, Mtb-specific peptides, TB participants demonstrate decreased IFN-γ production by CD4 and CD8 T cells.
(S1B) Staphylococcal-enterotoxin B (SEB) immune response: CITRUS analysis demonstrates CD4, CD8 and NK cells with decreased Ki-67 and IFN-γ. (S1C) PD-1 NK cells: CITRUS analysis identifies TB patients to have increased frequency of PD-1 expressing NK cells compared to healthy controls.
Supplemental Figure 2:
Venn Diagram demonstrates overlap of in vivo DNA hyper-methylation in TB patients from Eswatini with previously published in vitro DNA hyper-methylation (Sharma et al).
Venn diagram of genes with DNA hyper-methylation in CD4, CD8, CD56 and CD14 cells from this cohort of TB patients.
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